Acurx pharmaceuticals, inc. reports third quarter 2022 results and provides business update

Staten island, n.y. , nov. 14, 2022 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the quarter ended september 30, 2022.

ACXP Ratings Summary

ACXP Quant Ranking